News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Biogen
NEWS
JOBS
IN THE PRESS
NEWS
Drug Development
Advancing Biogen’s Alzheimer’s Treatment Could Cost $2.5 Billion Before Knowing if the Drug Works
April 28, 2015
·
3 min read
Deals
Sobi Waves For Sale Sign at Big Pharmas Like Pfizer, Biogen
April 27, 2015
·
1 min read
Genetown
Can Biogen Really Beat Alzheimer’s?
April 24, 2015
·
1 min read
Job Trends
Biogen Loaded With Talented Women Execs, as CEO Pushes to Diversify Boardroom
April 22, 2015
·
2 min read
Drug Development
Roche Still Bullish on Alzheimer’s Research After Biogen’s Successful Clinical Trial
April 22, 2015
·
2 min read
Drug Development
Biogen Shoots Up Following Positive Eye Drug RENEW Trial Data
April 15, 2015
·
3 min read
Deals
Three Biotechs Well-Positioned for M&A: Gilead, Celgene, and Biogen
April 14, 2015
·
2 min read
Genetown
Death Possibly Linked to Biogen Tecfidera “No Cause for Alarm,” Says Analyst
April 10, 2015
·
3 min read
Policy
Patient Dies Using Drug With Active Ingredients Like Biogen’s Tecfidera
April 9, 2015
·
2 min read
AWARDS
JOBS
Currently, there are no jobs for this company on BioSpace
Browse all jobs
here
Oops!
There was an issue retrieving the jobs list. Please reload the page to view more jobs.
Title
Location
Company Name
Desc
View details
IN THE PRESS
Press Releases
Ionis completes enrollment in pivotal cohort of the Phase 3 REVEAL study evaluating obudanersen in Angelman syndrome
July 6, 2026
·
6 min read
Press Releases
Samsung Bioepis Relaunches BYOOVIZ® (ranibizumab-nuna) in the United States in Partnership with Harrow
July 1, 2026
·
8 min read
Press Releases
Biogen to Highlight Breadth of Alzheimer’s Disease Portfolio at AAIC 2026, Including Phase 2 CELIA Data for Diranersen
June 29, 2026
·
13 min read
Press Releases
Biogen Expands Immunology Pipeline with Agreement to Acquire RayThera Inc.
June 18, 2026
·
8 min read
Press Releases
New Progress Toward Public Reimbursement of SKYCLARYS™ for People Living with Friedreich Ataxia in Quebec
June 8, 2026
·
4 min read
Press Releases
FNIH Names Recipients of the 2026 Charles A. Sanders, MD, Partnership Award
June 4, 2026
·
3 min read
Press Releases
Biogen’s Salanersen Receives FDA Breakthrough Therapy Designation for Spinal Muscular Atrophy
June 4, 2026
·
13 min read
Press Releases
EULAR 2026: Dapirolizumab Pegol Shows Potential to Reduce Flare Rates and Maintain Disease Control in Systemic Lupus Erythematosus
June 4, 2026
·
18 min read
Press Releases
Biogen Announces Upcoming Kidney Presentations at European Renal Association and American Transplant Congresses
June 3, 2026
·
20 min read
Press Releases
UCB and Biogen Announce Publication in The Lancet of Positive Dapirolizumab Pegol (DZP) Phase 3 Study Results in Systemic Lupus Erythematosus
June 1, 2026
·
16 min read
